EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk of cutaneous adverse reactions to lamotrigine and levetiracetam by age, sex, and reproductive status

Takafumi Abe, Shuichiro Neshige, Narumi Ohno, Keito Ishihara, Riho Okada, Yu Yamazaki, Koji Iida, Hirofumi Maruyama

Epilepsy & Behavior · 2026-11 · 184 · 111246

DOI: 10.1016/j.yebeh.2026.111246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026-11. Verfasst von Takafumi Abe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan. Hauptthemen laut MEDLINE: Lamotrigine, Levetiracetam, Anticonvulsants. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess the risk of cutaneous adverse drug reactions (CADRs) to lamotrigine (LTG) and levetiracetam (LEV) in relation to age, sex, and reproductive status. METHODS: We examined 3,379 patients (mean age: 38.2 ± 23.9 years; 49.3% women) who initiated LTG (n = 1,040) or LEV (n = 2,339) between 2008 and 2024. The frequency and severity of CADRs induced by each drug were evaluated. Patients were categorized by age pediatric (0-14 years), young and middle-aged adults (15-64 years), and older adults (≥65 years). We performed univariate and multivariate analyses to identify factors associated with CADR occurrence, including reproductive status. We also assessed age-related trends in CADR frequency and examined the presence of CADRs in relation to childbirth events. RESULTS: The frequency of LTG-induced CADRs was 3.2% (n = 33), including six severe cases (0.58%). Female sex was independently associated with LTG-induced CADRs (odds ratio = 2.44, p = 0.022). Among young and middle-aged adults, LTG-induced CADRs were more frequent in women than in men (5.0% vs. 1.4%,p = 0.013). The frequency exhibited an age-related increasing trend across the premenopausal period (p = 0.019) and declined sharply after menopause. Conversely, LEV-induced CADRs were rare (0.086%), mild, and not significantly associated with age or sex. Among 63 childbirth events, no CADRs occurred during the pregnancy period. CONCLUSIONS: LTG-induced CADRs occurred more frequently in women of reproductive age, whereas LEV demonstrated a favorable safety profile. These findings suggest that age- and sex-related clinical factors, including pregnancy-related information, may be associated with the frequency of LTG-induced CADRs; however, the role of hormonal factors, including hormonal contraception, requires further prospective investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LamotrigineLevetiracetamAnticonvulsantsHumansFemaleAdultMiddle AgedMaleYoung AdultAdolescentAgedChildAge FactorsInfantChild, PreschoolInfant, NewbornEpilepsySex Factors

Stichwörter der Autor:innen

LamotrigineLevetiracetamSex differencesWomen of reproductive ageantiseizure medications (ASMs)cutaneous adverse drug reactions (CADRs)

Substanzen

LamotrigineLevetiracetamAnticonvulsants

Autor:innen und Institutionen

  • Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.
  • Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan; Epilepsy Center, Hiroshima University Hospital, Japan. Electronic address: s-neshige@…
  • Epilepsy Center, Hiroshima University Hospital, Japan.
  • Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan; Epilepsy Center, Hiroshima University Hospital, Japan.

Zitieren

APA

Abe, T., Neshige, S., Ohno, N., Ishihara, K., Okada, R., Yamazaki, Y., Iida, K., & Maruyama, H. (2026). Risk of cutaneous adverse reactions to lamotrigine and levetiracetam by age, sex, and reproductive status. Epilepsy & Behavior, 184, 111246. https://doi.org/10.1016/j.yebeh.2026.111246

Vancouver

Abe T, Neshige S, Ohno N, Ishihara K, Okada R, Yamazaki Y, et al. Risk of cutaneous adverse reactions to lamotrigine and levetiracetam by age, sex, and reproductive status. Epilepsy & Behavior. 2026;184:111246. doi:10.1016/j.yebeh.2026.111246

BibTeX
@article{Abe2026,
  author = {Abe, Takafumi and Neshige, Shuichiro and Ohno, Narumi and Ishihara, Keito and Okada, Riho and Yamazaki, Yu and Iida, Koji and Maruyama, Hirofumi},
  title = {Risk of cutaneous adverse reactions to lamotrigine and levetiracetam by age, sex, and reproductive status},
  journal = {Epilepsy & Behavior},
  year = {2026},
  volume = {184},
  pages = {111246},
  doi = {10.1016/j.yebeh.2026.111246}
}
Kostenlos starten →